AbbVie: Q4 below estimates

(CercleFinance.com) - Published this Friday before Wall Street opens, AbbVie's Q4 2018 results fell short of analysts' expectations.


They included EPS of 1.90 dollar, up 28.4% y-o-y, falling short of the consensus of 1.94 dollar. Meanwhile, revenues came in at 8.3 billion dollars, up 8.3% in adjusted terms.

Finally, Abbvie reported FY adjusted EPS of 7.91 dollars, up 41.3%, while revenues rose by 15.2% to 32.74 billion dollars.


Copyright (c) 2019 CercleFinance.com. All rights reserved.